Breast Carcinoma by Gene Expression Profile

Breast Carcinoma by Gene Expression Profile — Trials · CancerIndex

Clinical trials

Registered studies

1,299 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 537
Recruiting: 295
Ph III recruiting: 37
Growth YoY: +3.8%
Industry share: 28%
Top sponsor: Fudan University
Termination share: 46%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (217)

clinicaltrialsPublishedShowing 651–660 of 660 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01969032	Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer	completed	Phase 2	41	Russian Academy of Medical SciencesOTHER	1	Nov 5, 2014	clinicaltrials
NCT00079326	Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer	terminated	Phase 2	39	National Cancer Institute (NCI)NIH	1	Jun 2, 2014	clinicaltrials